PATENTED MEDICINES PRICE REFORM : BIOQUÉBEC CONTINUES TO LEND ITS VOICE TO IMPORTANT POSITION STATEMENTS

← Back to the articles

This week, on behalf of its members, BIOQuébec signed a letter adressing the Patented Medicines Price Reform with some of OUR industry's MOST PROMINENT stakeholders.

collaboration-community-cooperation-872955 (1).jpg

Read the official letter

← Back to the articles

NewsGuest UserAugust 23, 2018Life Science Ontario, BioAlberta, Montréal InVivo, Québec International, PEI BioAlliance, NÉOMED, Life Sciences BC, New Brunswick Health Research Foundation